Review of the safety and efficacy of imiglucerase treatment of Gaucher disease
Deborah Elstein, Ari ZimranGaucher Clinic, Shaare Zedek Medical Center, Jerusalem, IsraelAbstract: Most patients who suffer from symptomatic Gaucher disease will benefit from enzyme replacement therapy (ERT) with imiglucerase. The safety profile is excellent, only a small percentage of those exposed...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2009
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/93035db7d71c4af793571bee8f3201da |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|